Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)
Clinical trial NCT00723710 · COMPLETED
Trial details
- NCT number
- NCT00723710
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2006-04-01
- Primary completion
- 2012-09-01
- Enrollment
- 299
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.